help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on August 28, 2003, doi:10.1164/rccm.200305-628OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200305-628OCv1
168/10/1223    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Middleton, P. G.
Right arrow Articles by Alton, E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Middleton, P. G.
Right arrow Articles by Alton, E. W.
American Journal of Respiratory and Critical Care Medicine Vol 168. pp. 1223-1226, (2003)
© 2003 American Thoracic Society

Airway Surface Liquid Calcium Modulates Chloride Permeability in the Cystic Fibrosis Airway

Peter G. Middleton, Katy A. Pollard, Elizabeth Donohoo, John R. Wheatley, Duncan M. Geddes and Eric W. Alton

Cystic Fibrosis Unit, Department of Respiratory Medicine, Westmead Hospital, Westmead, New South Wales, Australia; and Department of Gene Therapy, Faculty of Medicine, Imperial College at the National Heart and Lung Institute, London, United Kingdom

Correspondence and requests for reprints should be addressed to Peter G. Middleton, M.B.B.S., B.Sc. (Med), Ph.D., F.R.A.C.P., University of Sydney, Cystic Fibrosis Unit, Department of Respiratory Medicine, Westmead Hospital, Westmead 2145, New South Wales, Australia. E-mail: peterm{at}westgate.wh.usyd.edu.au

Patients with cystic fibrosis (CF) demonstrate a characteristic defect in epithelial chloride movement, which can be demonstrated in vivo by the nasal potential difference technique. After amiloride pretreatment, the CF airway exhibits only a transient response to perfusion with low-chloride solution, contrasting with the sustained hyperpolarization seen in control subjects. This study further investigated the response to low-chloride solution in the CF airway, examining the interaction between surface divalent ions and the low-chloride response. Sequential perfusion with amiloride, low chloride, and isoproterenol was tested in groups of subjects with CF, with the diluent containing different concentrations of calcium and magnesium, on different days. When the low-chloride response was measured with the nominally calcium-free diluents, the subjects with CF had mean (SEM) responses of 8.0 (0.7), 8.6 (2.4), and 9.6 (1.6) mV in the presence of 0, 1, and 3 mM Mg2+, respectively, significantly different from the response in the presence of divalent ions. However, the subsequent response to isoproterenol was not different in the presence or absence of divalent ions. We hypothesize that perfusion of the CF airway with nominally calcium-free solutions reduces tonic inhibition of chloride secretion.

Key Words: cystic fibrosis • potential difference • chloride • calcium




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 277 - 287.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society